This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: statins

November 2006 Br J Cardiol 2006;13:367-9

The impact of the new GP contract on measurement of lipids and use of statins in the over 80s with coronary heart disease

Samira Siddiqui, Chris Isles, Ewan Bell, Alan Begg

Abstract

No content available

| Full text

May 2006 Br J Cardiol 2006;13:196-202

Cost-effectiveness of rosuvastatin, atorvastatin, simvastatin, pravastatin and fluvastatin for the primary prevention of CHD in the UK

Andrew Davies, John Hutton, John O'donnell, Sarah Kingslake

Abstract

No content available

| Full text

May 2006 Br J Cardiol 2006;13:205-208

Do fibrates offer special benefits in treating diabetic dyslipidaemia? Lessons from FIELD

Hugh F McIntyre

Abstract

No content available

| Full text

September 2005 Br J Cardiol 2005;12:397-400

Statin prescribing: is the reality meeting the expectations of primary care?

Adrian JB Brady, John Norrie, Ian Ford

Abstract

No content available

| Full text

September 2005 Br J Cardiol 2005;12:379-86

New approaches to the management of dyslipidaemia

Lena M Izzat, Philip Avery

Abstract

No content available

| Full text

November 2004 Br J Cardiol 2004;11:487-91

Statins in primary care: bridging the treatment gap

Rubin Minhas

Abstract

No content available

| Full text

November 2004 Br J Cardiol 2004;11:455-60

Should all diabetic patients receive a statin? Results from recent trials

Gillian Marshall, Claire McDougall, Adrian JB Brady, Miles Fisher

Abstract

No content available

| Full text

November 2004 Br J Cardiol 2004;11:449-54

Statin safety in perspective – maximising the risk:benefit

Marc Evans

Abstract

No content available

| Full text

July 2004 Br J Cardiol 2004;11:282-6

The National Cholesterol Education Program III scoring system for CHD risk estimation cannot be used with European recommendations

Navneet Singh, See Kwok, C Jeffrey Seneviratne, Michael France, Paul Durrington

Abstract

No content available

| Full text

March 2004 Br J Cardiol 2004;11:129-36

Evolution of the HMG CoA reductase inhibitors (statins) in cardiovascular medicine

Christopher J Packard

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now